Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 289

1.

Determinants of diagnostic delay in Chronic Thromboembolic Pulmonary Hypertension: results from the European CTEPH registry.

Klok FA, Barco S, Konstantinides SV, Dartevelle P, Fadel E, Jenkins D, Kim NH, Madani M, Matsubara H, Mayer E, Pepke-Zaba J, Delcroix M, Lang IM.

Eur Respir J. 2018 Nov 8. pii: 1801687. doi: 10.1183/13993003.01687-2018. [Epub ahead of print] No abstract available.

PMID:
30409820
2.

Chronic Thromboembolic Pulmonary Hypertension and Antiphospholipid Syndrome with Immune Thrombocytopenia: A Case Report.

Skride A, Sablinskis M, Sablinskis K, Lejniece S, Lejnieks A, Klepetko W, Lang IM.

Am J Case Rep. 2018 Oct 19;19:1245-1248. doi: 10.12659/AJCR.909778.

3.

The Effects of Esophageal Acidification on Esophageal Reflexes Controlling the Upper Esophageal Sphincter.

Lang IM, Medda BK, Shaker R.

Am J Physiol Gastrointest Liver Physiol. 2018 Oct 11. doi: 10.1152/ajpgi.00292.2018. [Epub ahead of print]

PMID:
30308131
4.

Association of Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio with the Risk of Thromboembolism and Mortality in Patients with Cancer.

Grilz E, Posch F, Königsbrügge O, Schwarzinger I, Lang IM, Marosi C, Pabinger I, Ay C.

Thromb Haemost. 2018 Nov;118(11):1875-1884. doi: 10.1055/s-0038-1673401. Epub 2018 Oct 8.

PMID:
30296815
5.

Chronic thromboembolic pulmonary hypertension (CTEPH): Updated Recommendations from the Cologne Consensus Conference 2018.

Wilkens H, Konstantinides S, Lang IM, Bunck AC, Gerges M, Gerhardt F, Grgic A, Grohé C, Guth S, Held M, Hinrichs JB, Hoeper MM, Klepetko W, Kramm T, Krüger U, Lankeit M, Meyer BC, Olsson KM, Schäfers HJ, Schmidt M, Seyfarth HJ, Ulrich S, Wiedenroth CB, Mayer E.

Int J Cardiol. 2018 Aug 28. pii: S0167-5273(18)34354-7. doi: 10.1016/j.ijcard.2018.08.079. [Epub ahead of print]

PMID:
30195840
6.

2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy.

Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífková R, De Bonis M, Iung B, Johnson MR, Kintscher U, Kranke P, Lang IM, Morais J, Pieper PG, Presbitero P, Price S, Rosano GMC, Seeland U, Simoncini T, Swan L, Warnes CA; ESC Scientific Document Group .

Eur Heart J. 2018 Sep 7;39(34):3165-3241. doi: 10.1093/eurheartj/ehy340. No abstract available.

PMID:
30165544
7.

9-year clinical follow-up of patients with ST-segment elevation myocardial infarction with Genous or TAXUS Liberté stents.

Giurgea GA, Heuberger A, Babayev J, Winkler S, Schlager O, Lang IM, Gyöngyösi M.

PLoS One. 2018 Aug 6;13(8):e0201416. doi: 10.1371/journal.pone.0201416. eCollection 2018.

8.

Altered structure and function of fibrinogen after cleavage by Factor VII Activating Protease (FSAP).

Etscheid M, Subramaniam S, Lochnit G, Zabczyk M, Undas A, Lang IM, Hanschmann KM, Kanse SM.

Biochim Biophys Acta Mol Basis Dis. 2018 Oct;1864(10):3397-3406. doi: 10.1016/j.bbadis.2018.07.030. Epub 2018 Aug 1.

PMID:
30076961
9.

Lipid profile and long-term outcome in premature myocardial infarction.

Winter MP, Wiesbauer F, Blessberger H, Pavo N, Sulzgruber P, Huber K, Wojta J, Distelmaier K, Lang IM, Goliasch G.

Eur J Clin Invest. 2018 Oct;48(10):e13008. doi: 10.1111/eci.13008. Epub 2018 Aug 13.

PMID:
30062727
10.

Polyunsaturated fatty acids supplementation impairs anti-oxidant high-density lipoprotein function in heart failure.

Wurm R, Schrutka L, Hammer A, Moertl D, Berger R, Pavo N, Lang IM, Goliasch G, Huelsmann M, Distelmaier K.

Eur J Clin Invest. 2018 Sep;48(9):e12998. doi: 10.1111/eci.12998. Epub 2018 Aug 1.

11.

Usefulness of thrombosis and inflammation biomarkers in chronic thromboembolic pulmonary hypertension-sampling plasma and surgical specimens.

Skoro-Sajer N, Gerges C, Gerges M, Panzenböck A, Jakowitsch J, Kurz A, Taghavi S, Sadushi-Kolici R, Campean I, Klepetko W, Celermajer DS, Lang IM.

J Heart Lung Transplant. 2018 Sep;37(9):1067-1074. doi: 10.1016/j.healun.2018.04.003. Epub 2018 Apr 25.

PMID:
29802084
12.

The Long-Term Impact of Post-Procedural Asymmetry and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial.

Katagiri Y, Serruys PW, Macaya C, Ormiston JA, Hill J, Lang IM, Egred M, Fajadet J, Lesiak M, Wykrzykowska JJ, Piek JJ, Sabaté M, Windecker S, Chevalier B, Onuma Y.

JACC Cardiovasc Interv. 2018 May 28;11(10):1013-1015. doi: 10.1016/j.jcin.2018.02.020. No abstract available.

PMID:
29798767
13.

What is new in the 2017 ESC clinical practice guidelines : Management of acute myocardial infarction in patients presenting with ST-segment elevation.

Lang IM.

Wien Klin Wochenschr. 2018 Jul;130(13-14):421-426. doi: 10.1007/s00508-018-1333-0. Epub 2018 May 23. Review.

14.

Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer.

Grilz E, Königsbrügge O, Posch F, Schmidinger M, Pirker R, Lang IM, Pabinger I, Ay C.

Haematologica. 2018 Sep;103(9):1549-1556. doi: 10.3324/haematol.2018.192419. Epub 2018 May 24.

15.

Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy.

Siller-Matula JM, Pecen L, Patti G, Lucerna M, Kirchhof P, Lesiak M, Huber K, Verheugt FWA, Lang IM, Renda G, Schnabel RB, Wachter R, Kotecha D, Sellal JM, Rohla M, Ricci F, De Caterina R; TEAM in AF group.

Int J Cardiol. 2018 Aug 15;265:141-147. doi: 10.1016/j.ijcard.2018.04.093. Epub 2018 Apr 22.

PMID:
29706429
16.

In-depth haemodynamic phenotyping of pulmonary hypertension due to left heart disease.

Gerges C, Gerges M, Fesler P, Pistritto AM, Konowitz NP, Jakowitsch J, Celermajer DS, Lang IM.

Eur Respir J. 2018 May 24;51(5). pii: 1800067. doi: 10.1183/13993003.00067-2018. Print 2018 May.

PMID:
29599186
17.

Evolution of secondary mitral regurgitation.

Bartko PE, Pavo N, Pérez-Serradilla A, Arfsten H, Neuhold S, Wurm R, Lang IM, Strunk G, Dal-Bianco JP, Levine RA, Hülsmann M, Goliasch G.

Eur Heart J Cardiovasc Imaging. 2018 Jun 1;19(6):622-629. doi: 10.1093/ehjci/jey023.

PMID:
29534164
18.

Sex Difference in Patients With Ischemic Heart Failure Undergoing Surgical Revascularization: Results From the STICH Trial (Surgical Treatment for Ischemic Heart Failure).

Piña IL, Zheng Q, She L, Szwed H, Lang IM, Farsky PS, Castelvecchio S, Biernat J, Paraforos A, Kosevic D, Favaloro LE, Nicolau JC, Varadarajan P, Velazquez EJ, Pai RG, Cyrille N, Lee KL, Desvigne-Nickens P; STICH Trial Investigators.

Circulation. 2018 Feb 20;137(8):771-780. doi: 10.1161/CIRCULATIONAHA.117.030526.

PMID:
29459462
19.

Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for Mortality.

McLaughlin VV, Hoeper MM, Channick RN, Chin KM, Delcroix M, Gaine S, Ghofrani HA, Jansa P, Lang IM, Mehta S, Pulido T, Sastry BKS, Simonneau G, Sitbon O, Souza R, Torbicki A, Tapson VF, Perchenet L, Preiss R, Verweij P, Rubin LJ, Galiè N.

J Am Coll Cardiol. 2018 Feb 20;71(7):752-763. doi: 10.1016/j.jacc.2017.12.010.

20.

Subcutaneous treprostinil in congenital heart disease-related pulmonary arterial hypertension.

Skoro-Sajer N, Gerges C, Balint OH, Kohalmi D, Kaldararova M, Simkova I, Jakowitsch J, Gabriel H, Baumgartner H, Gerges M, Sadushi-Kolici R, Celermajer DS, Lang IM.

Heart. 2018 Jul;104(14):1195-1199. doi: 10.1136/heartjnl-2017-312143. Epub 2018 Feb 7.

21.

Duration of extracorporeal membrane oxygenation support and survival in cardiovascular surgery patients.

Distelmaier K, Wiedemann D, Binder C, Haberl T, Zimpfer D, Heinz G, Koinig H, Felli A, Steinlechner B, Niessner A, Laufer G, Lang IM, Goliasch G.

J Thorac Cardiovasc Surg. 2018 Jun;155(6):2471-2476. doi: 10.1016/j.jtcvs.2017.12.079. Epub 2017 Dec 26.

PMID:
29395201
22.

Targeting the Prostacyclin Pathway with Selexipag in Patients with Pulmonary Arterial Hypertension Receiving Double Combination Therapy: Insights from the Randomized Controlled GRIPHON Study.

Coghlan JG, Channick R, Chin K, Di Scala L, Galiè N, Ghofrani HA, Hoeper MM, Lang IM, McLaughlin V, Preiss R, Rubin LJ, Simonneau G, Sitbon O, Tapson VF, Gaine S.

Am J Cardiovasc Drugs. 2018 Feb;18(1):37-47. doi: 10.1007/s40256-017-0262-z.

23.

Dabigatran after Short Heparin Anticoagulation for Acute Intermediate-Risk Pulmonary Embolism: Rationale and Design of the Single-Arm PEITHO-2 Study.

Klok FA, Ageno W, Barco S, Binder H, Brenner B, Duerschmied D, Empen K, Faggiano P, Ficker JH, Galiè N, Ghuysen A, Held M, Heydenreich N, Huisman MV, Jiménez D, Kozak M, Lang IM, Lankeit M, Münzel T, Petris A, Pruszczyk P, Quitzau K, Schellong S, Schmidt KH, Stefanovic BS, Verschuren F, Wolf-Puetz A, Meyer G, Konstantinides SV; PEITHO-2 Investigators.

Thromb Haemost. 2017 Dec;117(12):2425-2434. doi: 10.1160/TH17-06-0434. Epub 2017 Dec 6.

PMID:
29212130
24.

Interaction of factor VII activating protease (FSAP) with neutrophil extracellular traps (NETs).

Grasso S, Neumann A, Lang IM, Etscheid M, von Köckritz-Blickwede M, Kanse SM.

Thromb Res. 2018 Jan;161:36-42. doi: 10.1016/j.thromres.2017.11.012. Epub 2017 Nov 21.

PMID:
29178989
25.

Sublingual functional capillary rarefaction in chronic heart failure.

Wadowski PP, Hülsmann M, Schörgenhofer C, Lang IM, Wurm R, Gremmel T, Koppensteiner R, Steinlechner B, Schwameis M, Jilma B.

Eur J Clin Invest. 2018 Feb;48(2). doi: 10.1111/eci.12869. Epub 2017 Dec 14.

PMID:
29178250
26.

Decreased platelet inhibition by P2Y12 receptor blockers in anaemia.

Wadowski PP, Kopp CW, Koppensteiner R, Lang IM, Pultar J, Lee S, Weikert C, Panzer S, Gremmel T.

Eur J Clin Invest. 2018 Jan;48(1). doi: 10.1111/eci.12861. Epub 2017 Dec 7.

PMID:
29171876
27.

The effect of body position on esophageal reflexes in cats: a possible mechanism of SIDS?

Lang IM, Medda BK, Shaker R, Jadcherla S.

Pediatr Res. 2018 Mar;83(3):731-738. doi: 10.1038/pr.2017.302. Epub 2017 Dec 20.

28.

Temporary treatment interruptions with oral selexipag in pulmonary arterial hypertension: Insights from the Prostacyclin (PGI2) Receptor Agonist in Pulmonary Arterial Hypertension (GRIPHON) study.

Preston IR, Channick RN, Chin K, Di Scala L, Farber HW, Gaine S, Galiè N, Ghofrani HA, Hoeper MM, Lang IM, McLaughlin VV, Preiss R, Simonneau G, Sitbon O, Tapson VF, Rubin LJ.

J Heart Lung Transplant. 2018 Mar;37(3):401-408. doi: 10.1016/j.healun.2017.09.024. Epub 2017 Oct 2.

PMID:
29096938
29.

Pulmonary Hypertension Due to Left Heart Disease.

Gerges M, Gerges C, Naeije R, Lang IM.

Semin Respir Crit Care Med. 2017 Oct;38(5):662-676. doi: 10.1055/s-0037-1606576. Epub 2017 Oct 15. No abstract available.

PMID:
29032567
30.

Refining the prognostic impact of functional mitral regurgitation in chronic heart failure.

Goliasch G, Bartko PE, Pavo N, Neuhold S, Wurm R, Mascherbauer J, Lang IM, Strunk G, Hülsmann M.

Eur Heart J. 2018 Jan 1;39(1):39-46. doi: 10.1093/eurheartj/ehx402.

PMID:
29020337
31.

Distinguishing Chronic Thromboembolic Pulmonary Hypertension From Other Causes of Pulmonary Hypertension Using CT.

Grosse A, Grosse C, Lang IM.

AJR Am J Roentgenol. 2017 Dec;209(6):1228-1238. doi: 10.2214/AJR.17.17871. Epub 2017 Oct 5.

PMID:
28981358
32.

Normal values for Doppler echocardiographic assessment of prosthetic valve function after transcatheter aortic valve replacement: a systematic review and meta-analysis.

Winter MP, Zbiral M, Kietaibl A, Sulzgruber P, Kastner J, Rosenhek R, Binder T, Lang IM, Goliasch G.

Eur Heart J Cardiovasc Imaging. 2018 Apr 1;19(4):361-368. doi: 10.1093/ehjci/jex212.

PMID:
28950312
33.

Management and clinical outcome of stable coronary artery disease in Austria : Results from 5 years of the CLARIFY registry.

Lang IM, Badr-Eslam R, Greenlaw N, Young R, Steg PG.

Wien Klin Wochenschr. 2017 Dec;129(23-24):879-892. doi: 10.1007/s00508-017-1248-1. Epub 2017 Sep 14.

34.

Hemodynamic Phenotyping of Pulmonary Hypertension in Left Heart Failure.

Naeije R, Gerges M, Vachiery JL, Caravita S, Gerges C, Lang IM.

Circ Heart Fail. 2017 Sep;10(9). pii: e004082. doi: 10.1161/CIRCHEARTFAILURE.117.004082. Review.

PMID:
28912263
35.

Maturation Modulates Pharyngeal-Stimulus Provoked Pharyngeal and Respiratory Rhythms in Human Infants.

Hasenstab KA, Sitaram S, Lang IM, Shaker R, Jadcherla SR.

Dysphagia. 2018 Feb;33(1):63-75. doi: 10.1007/s00455-017-9833-z. Epub 2017 Aug 21.

PMID:
28828751
36.

Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension.

Gaine S, Chin K, Coghlan G, Channick R, Di Scala L, Galiè N, Ghofrani HA, Lang IM, McLaughlin V, Preiss R, Rubin LJ, Simonneau G, Sitbon O, Tapson VF, Hoeper MM.

Eur Respir J. 2017 Aug 17;50(2). pii: 1602493. doi: 10.1183/13993003.02493-2016. Print 2017 Aug.

37.

Chronic complications of venous thromboembolism.

Winter MP, Schernthaner GH, Lang IM.

J Thromb Haemost. 2017 Aug;15(8):1531-1540. doi: 10.1111/jth.13741. Review.

PMID:
28762624
38.

Impact of Right Ventricular Performance in Patients Undergoing Extracorporeal Membrane Oxygenation Following Cardiac Surgery.

Bartko PE, Wiedemann D, Schrutka L, Binder C, Santos-Gallego CG, Zuckermann A, Steinlechner B, Koinig H, Heinz G, Niessner A, Zimpfer D, Laufer G, Lang IM, Distelmaier K, Goliasch G.

J Am Heart Assoc. 2017 Jul 28;6(8). pii: e005455. doi: 10.1161/JAHA.116.005455.

39.

Interdependence between osteoprotegerin and active von Willebrand factor in long-term cardiovascular mortality prediction in patients undergoing percutaneous coronary intervention.

Siller-Matula J, Lang IM, Schoergenhofer C, Roest M, Jilma B.

Thromb Haemost. 2017 Aug 30;117(9):1730-1738. doi: 10.1160/TH17-02-0087. Epub 2017 Jul 20.

PMID:
28726980
40.

Combined oral administration of L-arginine and tetrahydrobiopterin in a rat model of pulmonary arterial hypertension.

Schreiber C, Eilenberg MS, Panzenboeck A, Winter MP, Bergmeister H, Herzog R, Mascherbauer J, Lang IM, Bonderman D.

Pulm Circ. 2017 Apr 4;7(1):89-97. doi: 10.1086/689289. eCollection 2017 Mar.

41.

Arterial Remodeling After Bioresorbable Scaffolds and Metallic Stents.

Serruys PW, Katagiri Y, Sotomi Y, Zeng Y, Chevalier B, van der Schaaf RJ, Baumbach A, Smits P, van Mieghem NM, Bartorelli A, Barragan P, Gershlick A, Kornowski R, Macaya C, Ormiston J, Hill J, Lang IM, Egred M, Fajadet J, Lesiak M, Windecker S, Byrne RA, Räber L, van Geuns RJ, Mintz GS, Onuma Y.

J Am Coll Cardiol. 2017 Jul 4;70(1):60-74. doi: 10.1016/j.jacc.2017.05.028.

42.

Current understanding of the pathophysiology of chronic thromboembolic pulmonary hypertension.

Sharma S, Lang IM.

Thromb Res. 2018 Apr;164:136-144. doi: 10.1016/j.thromres.2017.06.011. Epub 2017 Jun 12. Review.

PMID:
28624155
43.

Characterization and mechanisms of the supragastric belch in the cat.

Lang IM, Medda BK, Shaker R.

Am J Physiol Gastrointest Liver Physiol. 2017 Sep 1;313(3):G220-G229. doi: 10.1152/ajpgi.00142.2017. Epub 2017 Jun 15.

44.

The Pulmonary Vascular Research Institute celebrates its first decade.

Yuan JX, Morrell NW, Stenmark KR, Lang IM, Butrous G, Reynolds ME.

Pulm Circ. 2017 Apr-Jun;7(2):283-284. doi: 10.1177/2045893217713107. No abstract available.

45.

Mortality in patients resuscitated from out-of-hospital cardiac arrest based on automated blood cell count and neutrophil lymphocyte ratio at admission.

Weiser C, Schwameis M, Sterz F, Herkner H, Lang IM, Schwarzinger I, Spiel AO.

Resuscitation. 2017 Jul;116:49-55. doi: 10.1016/j.resuscitation.2017.05.006. Epub 2017 May 2.

PMID:
28476480
46.

Clinical presentation and management of stable coronary artery disease in Austria.

Pichlhöfer O, Maier M, Badr-Eslam R, Ristl R, Zebrowska M, Lang IM.

PLoS One. 2017 Apr 27;12(4):e0176257. doi: 10.1371/journal.pone.0176257. eCollection 2017.

47.

Disaggregation Following Agonist-Induced Platelet Activation in Patients on Dual Antiplatelet Therapy.

Wadowski PP, Eichelberger B, Kopp CW, Pultar J, Seidinger D, Koppensteiner R, Lang IM, Panzer S, Gremmel T.

J Cardiovasc Transl Res. 2017 Aug;10(4):359-367. doi: 10.1007/s12265-017-9746-0. Epub 2017 Apr 19.

48.

Long-term outcome and risk assessment in premature acute myocardial infarction: A 10-year follow-up study.

Winter MP, Blessberger H, Alimohammadi A, Pavo N, Huber K, Wojta J, Lang IM, Wiesbauer F, Goliasch G.

Int J Cardiol. 2017 Aug 1;240:37-42. doi: 10.1016/j.ijcard.2017.03.146. Epub 2017 Apr 2.

PMID:
28395980
49.

Delayed coronary obstruction following Portico in Freedom Solo valve-in-valve implantation.

Kastner J, Goliasch G, Winter MP, Luha O, Andreas M, Lang IM.

Coron Artery Dis. 2017 Sep;28(6):528-529. doi: 10.1097/MCA.0000000000000487. No abstract available.

PMID:
28346286
50.

Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism.

Konstantinides SV, Vicaut E, Danays T, Becattini C, Bertoletti L, Beyer-Westendorf J, Bouvaist H, Couturaud F, Dellas C, Duerschmied D, Empen K, Ferrari E, Galiè N, Jiménez D, Kostrubiec M, Kozak M, Kupatt C, Lang IM, Lankeit M, Meneveau N, Palazzini M, Pruszczyk P, Rugolotto M, Salvi A, Sanchez O, Schellong S, Sobkowicz B, Meyer G.

J Am Coll Cardiol. 2017 Mar 28;69(12):1536-1544. doi: 10.1016/j.jacc.2016.12.039.

Supplemental Content

Support Center